Remdesivir Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

RecruitingTreatment3 IdentifierTitleDrugs
NCT04593940Immune Modulators for Treating COVID-19
NCT04843761ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
NCT04501978ACTIV-3: Therapeutics for Inpatients With COVID-19
NCT04745351Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)
NCT04694612Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal